Teleflex Executive and Leadership Team

John Deren, the Executive Vice President & Chief Financial Officer at Teleflex, directs all global financial operations and capital allocation strategies. Managing the fiscal health of the organization, the Executive Vice President & Chief Financial Officer oversees financial planning, reporting, and investor relations to ensure long-term stability. This leadership role involves rigorous analysis of market trends across the Americas, EMEA, and Asia Pacific to optimize resource distribution for medical device manufacturing. By maintaining strict compliance and transparency, John Deren supports the broader corporate mission of delivering high-quality surgical and critical care solutions. The Executive Vice President & Chief Financial Officer collaborates with the Board to drive sustainable growth and shareholder value. Through precise financial modeling and risk management, Deren secures the necessary capital to fund research and development initiatives, ultimately strengthening the market position of the company within the competitive medical technology landscape.

James Ferguson, the President & General Manager, Surgical at Teleflex, architects the strategic direction for the global surgical product portfolio. Overseeing the design, development, and manufacturing of specialized surgical instruments, the President & General Manager, Surgical ensures that healthcare providers receive reliable, single-use devices for complex procedures. This leadership role requires constant coordination with clinical teams to refine product efficacy and safety standards. By driving innovation in surgical applications, James Ferguson expands the reach of the company into new clinical environments across international markets. The President & General Manager, Surgical monitors operational efficiency to maintain high production standards while meeting the evolving needs of hospitals. Through effective management of the surgical division, Ferguson directly impacts the ability of the organization to provide critical support during therapeutic procedures. Ultimately, Ferguson ensures that the surgical business unit remains a cornerstone of the global medical technology strategy.

Praneet Mehrotra, the President, Asia Pacific at Teleflex, directs all commercial activities and market penetration strategies throughout the Asia Pacific region. Overseeing regional sales, distribution networks, and regulatory compliance, the President, Asia Pacific ensures that medical technology products reach healthcare providers efficiently across diverse markets. This leadership role involves adapting global product portfolios to meet specific regional clinical requirements and healthcare infrastructure needs. By fostering strong relationships with local hospitals and medical institutions, Praneet Mehrotra drives revenue growth and brand recognition in this high-potential geography. The President, Asia Pacific collaborates with global leadership to align regional objectives with the overarching corporate mission of improving patient care. Through strategic market development and operational oversight, Mehrotra expands the footprint of the company in critical care and surgical segments. Ultimately, Mehrotra secures a competitive advantage by navigating complex regulatory landscapes and delivering tailored medical solutions to the Asia Pacific healthcare sector.

Travis Gay, the President and General Manager, Interventional Urology at Teleflex, architects the growth strategy for the specialized urology product line. Overseeing the development and commercialization of diagnostic and therapeutic devices, the President and General Manager, Interventional Urology ensures that clinical teams have access to advanced tools for patient care. This leadership role involves managing the entire product lifecycle, from initial design to market launch, while maintaining high standards of quality and safety. By focusing on innovation within the urology segment, Travis Gay drives the adoption of new technologies that improve diagnostic accuracy and therapeutic outcomes. The President and General Manager, Interventional Urology coordinates with global sales and marketing teams to expand the presence of the company in both established and emerging markets. Through strategic leadership, Gay enhances the portfolio of the organization, ensuring that the urology division contributes significantly to the overall success of the medical technology business.